Format:
Online-Ressource (VIII, 288p. 61 illus)
,
online resource
Edition:
Springer eBook Collection. Medicine
ISBN:
9783709168929
Series Statement:
Journal of Neural Transmission Supplement 47
Content:
This volume gives an overview of the present state of art on the classification, neuropathology, clinical presentation, neuropsychology, diagnosis, neuroimaging and therapeutic possibilities in non-Alzheimer’s dementias, an increasingly important group of CNS diseases, which account for 7 to 30% of dementing disorders in adults and aged subjects, and thus, represent the second most frequent cause of dementia after Alzheimer’s disease. The monograph provides the newest information for neurologists, psychiatrists, dementia research workers, dementia clinicians, neuropathologists, neurobiologists, and practicing physicians
Note:
Structural basis of dementia in neurodegenerative disordersCytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in Diffuse Lewy body disease, Pick’s disease, and Corticobasal Degeneration -- The neuropathologic diagnostic criteria of frontal lobe dementia revisited. A study of ten consecutive cases -- Cognitive deficits in non-Alzheimer’s degenerative diseases -- The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared -- Clinical features of frontal lobe dementia in comparison to Alzheimer’s disease -- Frontal lobe dementia and motor neuron disease -- Clinical and pathological characteristics of primary progressive aphasia and frontal dementia -- MR-imaging of non-Alzheimer’s dementia -- Functional imaging techniques in the diagnosis of non-Alzheimer dementias -- Quantitative EEG in frontal lobe dementia -- Vascular dementia: perfusional and metabolic disturbances and effects of therapy -- The spectrum of depressive pseudo-dementia -- Molecular biology of APO E alleles in Alzheimer’s and non-Alzheimer’s dementias -- Transmissible cerebral amyloidosis -- Human prion diseases -- The survival response of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum: comparison with members of the TGF-? superfamily and characterization of the serum-free culture system -- Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer’s disease: impact on non-Alzheimer’s dementia? -- Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative Cerebrolysin® -- Molecular regulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived peptides -- Cerebrolysin® protects neurons from ischemia-induced loss of microtubule - associated protein 2 -- The long-term effect of NGF, b-FGF and Cerebrolysin® on the spatial memory after fimbria-fornix lesion in rats -- The influence of Cerebrolysin® and E021 on spatial navigation of young rats -- Effects of Cerebrolysin® on cytoskeletal proteins after focal ischemia in rats -- The short-term influence of b-FGF, NGF and Cerebrolysin® on the memory impaired after fimbria-fornix lesion -- Brain tissue hydrolysate, Cerebrolysin®, acts on presynaptic adenosine receptors in the rat hippocampus.
Additional Edition:
9783211828236
Language:
English
DOI:
10.1007/978-3-7091-6892-9
URL:
Volltext
(lizenzpflichtig)
Bookmarklink